Early intervention in pediatric-onset MS can lead to improved long-term outcomes
New research presented today at ECTRIMS 2024 reveals that initiating monoclonal antibody therapy during childhood, rather than delaying treatment until early adulthood, significantly reduces long-term disability in multiple sclerosis (MS) patients.
18 Sep 14:35 · News-Medical